Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Interest & Investment Income came in at $228000.0 in Q4 2025, down 42.86% YoY from $399000.0 in Q4 2024, and up 50.0% on a QoQ basis from $152000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Interest & Investment Income data on file, last reported at $228000.0 in Q4 2025.
- Quarterly Interest & Investment Income fell 42.86% year-over-year to $228000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $787000.0 (down 53.21% YoY) and the FY2025 annual result came in at $787000.0, down 53.21% from the prior year.
- Interest & Investment Income improved to $228000.0 in Q4 2025, from $152000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $570000.0 in Q2 2024 to a low of $9000.0 in Q1 2022.
- A 5-year average of $157950.0 and a median of $115000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 1177.78% — and 2025, when it plunged 70.54%.
- Tracing FENC's Interest & Investment Income over 5 years: stood at $13000.0 in 2021, then soared by 1076.92% to $153000.0 in 2022, then decreased by 24.84% to $115000.0 in 2023, then surged by 246.96% to $399000.0 in 2024, then plunged by 42.86% to $228000.0 in 2025.
- The last three Interest & Investment Income figures came in at $228000.0 (Q4 2025), $152000.0 (Q3 2025), and $171000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 287,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 287,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Sep 30, 2024 | 516,000.00 |
| Jun 30, 2024 | 570,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 115,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 153,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |